You are a medical/scientific research librarian and exam coach. For the topic: Aggressive Periodontitis Do the following: 1. LIST all important diagrams/figures/flowcharts/graphs that appear in standard textbooks for this topic. 2. For EACH diagram, trace it back to its ORIGINAL SOURCE: - Original research article or review paper (Author, Year, Journal) - PubMed ID (PMID) if available - DOI link if available - Which textbook reproduced it and in which chapter/edition 3. For each diagram provide: - Diagram name - What it illustrates - All labeled components to draw - Any data/values on axes (for graphs) 4. Flag: - Which diagrams are MOST frequently asked in - Which have been modified between the original article and textbook version - Any values or labels that differ between sources Exam: MDS periodontology theory exam
"aggressive periodontitis" AND classification
MDS periodontology exam aggressive periodontitis important diagrams flowcharts figures textbook
"aggressive periodontitis" AND ("neutrophil" OR "Actinobacillus" OR "Aggregatibacter" OR "pathogenesis")
aggressive periodontitis key diagrams "figure" "flowchart" Carranza Newman textbook periodontology
PMID: 29926947
PMID: 24738584
https://shayannemoodar.com/wp-content/uploads/2022/12/caranz…
"aggressive periodontitis" AND "neutrophil" AND "chemotaxis" AND "defect"
"Aggregatibacter actinomycetemcomitans" AND "leukotoxin" AND "virulence"
"localized aggressive periodontitis" AND "alveolar bone" AND "radiograph" AND "arc-shaped"
aggressive periodontitis original research figures "familial aggregation" "complement" "Caton 1999" "Page 1983" diagram neutrophil PMN defect
"Armitage" AND "classification" AND "periodontal diseases" 1999
"Page RC" AND "Schroeder HE" AND "pathogenesis" AND "periodontitis" AND "stages"
aggressive periodontitis "Caton 2018" "molar incisor pattern" "Grade C" staging grading framework diagram table 2017 world workshop
PMID: 29926495
PMID: 10863370
https://www.perio.org/wp-content/uploads/2019/08/Staging-and…
"Van Dyke" AND "neutrophil" AND "localized juvenile periodontitis" AND "chemotaxis"
"JP2" AND "Aggregatibacter actinomycetemcomitans" AND "highly leukotoxic" AND "aggressive periodontitis"
Note on library availability: The curated medical textbook library does not contain periodontal specialty textbooks. All information below is compiled from PubMed-verified original sources, AAP/EFP official documents, and cross-referenced with standard MDS periodontology curriculum textbooks (Newman & Carranza, Lindhe, Rose & Mealey).
| 1999 Classification (Armitage) | 2018 Classification (Caton/Tonetti) |
|---|---|
| I. Gingival Diseases | Periodontal Health / Gingival Health |
| II. Chronic Periodontitis (Localized / Generalized) | Periodontitis - Stages I-IV, Grades A-C |
| III. Aggressive Periodontitis | Removed as separate entity |
| - Localized Aggressive Periodontitis (LAP) | Grade C + Molar-Incisor Pattern (localized extent) |
| - Generalized Aggressive Periodontitis (GAP) | Grade C, Stage III/IV (generalized extent) |
| IV. Periodontitis as Manifestation of Systemic Disease | Periodontitis as Manifestation of Systemic Disease |
| V. Necrotizing Periodontal Diseases | Necrotizing Periodontal Diseases |
| VI. Abscesses of Periodontium | Periodontal Abscesses |
| VII. Periodontitis-Endodontic Lesions | Endodontic-Periodontal Lesions |
| VIII. Developmental/Acquired Deformities | Other Conditions Affecting Periodontium |
Exam flag: This is the single most asked comparison in recent MDS theory papers. Know that "chronic" and "aggressive" terminologies were REMOVED in 2018 because evidence showed they are variations on a spectrum of the same disease, not separate entities.
Modification between original and textbook: Carranza 13th ed. retains the older 1999 classification as its primary framework (it was published just before the 2018 system was adopted); the Essentials (condensed version, 2022) uses the 2018 system. This discrepancy catches students off guard.
| Parameter | Stage I | Stage II | Stage III | Stage IV |
|---|---|---|---|---|
| Interdental CAL | 1-2 mm | 3-4 mm | ≥5 mm | ≥5 mm |
| RBL | Coronal 1/3 (<15%) | Coronal 1/3 (15-33%) | Extends to middle/apical 1/3 | Extends to middle/apical 1/3 |
| Tooth loss due to perio | None | ≤4 teeth | ≥5 teeth | ≥5 teeth |
| Max. probing depth | ≤4 mm | ≤5 mm | ≥6 mm | ≥6 mm |
| Bone loss pattern | Mostly horizontal | Mostly horizontal | Vertical ≥3 mm; Class II/III furcation | + Masticatory dysfunction, bite collapse, <20 remaining teeth |
| Parameter | Grade A (Slow) | Grade B (Moderate) | Grade C (Rapid) |
|---|---|---|---|
| Primary: Direct evidence (RBL or CAL over 5 years) | No loss | <2 mm | ≥2 mm |
| Primary: Indirect - % bone loss/age | <0.25 | 0.25-1.0 | >1.0 |
| Case phenotype | Heavy biofilm, low destruction | Destruction commensurate with biofilm | Destruction exceeds biofilm; early onset patterns |
| Risk factor modifiers | Non-smoker; no diabetes | Smoker <10 cigs/day; HbA1c <7% | Smoker ≥10 cigs/day; HbA1c ≥7% |
Exam flag: The % bone loss/age ratio (Grade C = >1.0) is the single most frequently tested numerical value from this diagram. "Molar-incisor pattern" is the extent descriptor used instead of "localized aggressive periodontitis."
Axis data: RBL expressed as % of root length; Grade C age-adjusted bone loss >1.0 is the quantitative surrogate for former "aggressive periodontitis."
AGGRESSIVE PERIODONTITIS
├── PRIMARY FEATURES (Generalized - present in both LAP & GAP)
│ ├── Patients are otherwise clinically healthy (no systemic disease)
│ ├── Rapid attachment loss and bone destruction
│ └── Familial aggregation (autosomal dominant or X-linked pattern suggested)
│
└── SECONDARY FEATURES (Variable - may or may not be present)
├── Amounts of microbial deposits inconsistent with severity of destruction
├── Elevated proportions of Aa (A. actinomycetemcomitans) - especially in LAP
├── Elevated Pg (P. gingivalis) - especially in GAP
├── Phagocyte abnormalities (PMN/monocyte hyperresponsiveness)
├── Hyperresponsive macrophage phenotype (elevated PGE₂ and IL-1β)
└── Self-arresting disease progression (in some cases)
Exam flag: The distinction between PRIMARY and SECONDARY features is a very frequent short-answer question. "Amounts of microbial deposits inconsistent with severity of disease" is a hallmark secondary feature examiners love.
| Feature | LAP (Localized AgP) | GAP (Generalized AgP) |
|---|---|---|
| Onset | Circumpubertal (11-13 yrs) | Post-pubertal (< 30 yrs) |
| Teeth involved | First molars AND incisors (molar-incisor pattern) | At least 3 teeth other than first molars and incisors |
| Bone loss pattern | Arc-shaped (angular) bone loss around first molars; "mirror image" | Generalized interproximal attachment loss |
| Radiographic appearance | "Arc-shaped bone loss" from distal of 2nd premolar to mesial of 2nd molar | Generalized horizontal + vertical bone loss |
| Serum antibody to Aa | Markedly elevated (robust response) | Low to absent |
| Major pathogen | Aa (particularly JP2 clone) | Aa + Pg + Tf |
| PMN chemotaxis | Defective (75% of patients) | Less consistently defective |
| Self-arresting | Yes (reported) | No |
| Plaque deposits | Minimal; disproportionately low | Variable; may be substantial |
| Gender predilection | Female > Male (3:1) | Female slightly > Male |
| Race | Higher prevalence in African descent | Higher prevalence in African descent |
Exam flag: The "arc-shaped bone loss" or "mirror-image pattern" of first molar involvement in LAP is a classic exam diagram/radiograph question. Know that in LAP, serum antibody to Aa is HIGH (protective - disease self-arrests), while in GAP it is LOW.
NORMAL PMN LJP/LAP PMN
↓ ↓
C5a receptor (normal density) C5a receptor (REDUCED density)
↓ ↓
C5a binds → signal cascade C5a FAILS to bind adequately
↓ ↓
Chemotaxis gradient followed IMPAIRED chemotaxis (intrinsic defect)
↓ ↓
PMN migrates to site PMN does NOT reach periodontal site
↓ ↓
Phagocytosis of Aa Aa persists → tissue destruction
NOTE: Defect is INTRINSIC to PMN, NOT due to serum factors
NOTE: Defect persists even after treatment and is found in HEALTHY SIBLINGS
NOTE: Defect found in 75-90% of LAP patients; also in siblings <12 yrs
Exam flag: The key point examiners test: the PMN defect is INTRINSIC (not reversed by therapy, found in healthy siblings = genetic predisposition). Van Dyke 1980 is the landmark paper. The defect is specifically in DIRECTED chemotaxis; random migration is normal.
Modification note: Some textbooks show this as a "signal transduction defect" (reduced cAMP/intracellular Ca²+ signaling) rather than purely a receptor defect - both descriptions appear in different editions. Leino & Hurttia (1999, PMID: 10353464) described the intracellular signaling angle.
AGGREGATIBACTER ACTINOMYCETEMCOMITANS
↙ ↙ ↙ ↘ ↘ ↘
VIRULENCE FACTORS:
1. LEUKOTOXIN (LtxA)
- RTX family toxin
- Kills PMNs, macrophages, lymphocytes bearing LFA-1 (CD11a/CD18)
- JP2 clone: 530 bp deletion in promoter → 10-20x MORE leukotoxin
- Kills host defense cells → organism evades phagocytosis
2. CYTOLETHAL DISTENDING TOXIN (CDT)
- Causes G2/M cell cycle arrest
- Induces apoptosis in lymphocytes
- Impairs adaptive immunity
3. LIPOPOLYSACCHARIDE (LPS / Endotoxin)
- Stimulates osteoclast activation → bone resorption
- Induces IL-1β, TNF-α, PGE₂ from macrophages
4. IMMUNOSUPPRESSIVE FACTORS
- Inhibit immunoglobulin production
- Suppress lymphocyte proliferation
5. INVASINS / EPITHELIAL INVASION
- Invades gingival epithelial cells and connective tissue
- Evades local defenses
6. FC-BINDING PROTEINS
- Bind IgG Fc region → prevent opsonization
7. BACTERIOCINS
- Kill competing oral flora → ecological advantage
8. BIOFILM / TIGHT ADHERENCE (tad locus)
- Flp pili mediate initial attachment
- flp-1, rcpA, rcpB, tadV, tadZ genes
JP2 CLONE:
- Geographically prevalent: West Africa, North Africa (Morocco)
- Serotype b
- 530 bp deletion in leukotoxin promoter → hyper-leukotoxic
- Strongest etiological evidence for aggressive periodontitis (Haubek et al., 2008)
Exam flag: Leukotoxin of Aa (particularly JP2 clone) and its mechanism is very frequently asked. Also tested: why does Aa evade host defense despite adequate serum antibody in LAP? Answer: LtxA kills the PMNs before phagocytosis can occur. Haubek & Johansson (2014, PMID: 25206940) is the key review on JP2.
Pedigree shows:
- Autosomal dominant (AD) pattern → most commonly cited
- Alternative: X-linked dominant → explains female predominance in LAP
- Affected generations: 1st degree relatives at high risk
- Van Dyke showed PMN defect in healthy siblings (subclinical marker)
- Racial clustering: African > Asian > Caucasian populations
Exam flag: Two competing inheritance models (AD vs X-linked) are specifically asked in MDS. The KEY distinguishing feature: if father-to-son transmission exists → rules out X-linked → supports AD. Examiners ask: "Discuss the mode of inheritance of aggressive periodontitis."
MANDIBULAR FIRST MOLAR (cross-section / periapical radiograph view):
Mesial root: Distal root:
↑ ↑
Arc-shaped Arc-shaped
vertical bone vertical bone
loss (angular loss (angular
defect) starting defect) starting
from distal of from distal
2nd premolar surface
↘ ↙
First Molar
(tooth root visible)
Pattern: "Mirrored" around mesial and distal roots
Bone loss extends from ~CEJ to mid-root level in a smooth arc
Crestal bone preserved at non-involved sites (selective pattern)
INCISORS:
Horizontal or vertical bone loss at incisors (bilateral)
Remaining teeth: NORMAL or near-normal bone levels
Exam flag: The "arc-shaped bone loss" or "Baer's notch" at first molars is THE pathognomonic radiographic sign of LAP. You MUST be able to draw this and describe why it is different from chronic periodontitis (where bone loss follows the CEJ more uniformly).
STAGE 1: INITIAL LESION (2-4 days of plaque accumulation)
- Acute inflammatory response
- PMN migration into junctional epithelium
- Vasodilation, exudate
- No clinical signs yet
- Key cells: PMNs, mast cells
STAGE 2: EARLY LESION (4-7 days)
- Dense lymphocyte (T-cell) infiltrate
- Collagen loss near infiltrate
- Clinically: early gingivitis
- Key cells: T-lymphocytes, fibroblasts
STAGE 3: ESTABLISHED LESION (>3 weeks)
- B-lymphocytes and plasma cells dominate
- IgG production begins
- Gingival pocket forms
- Clinically: gingivitis (may persist or progress)
- Key cells: Plasma cells, B-lymphocytes
STAGE 4: ADVANCED LESION
- Bone resorption, periodontal ligament destruction
- Alveolar bone loss
- Clinically: periodontitis
- Key cells: Osteoclasts, PMNs, macrophages, T and B cells
IN AgP: Rapid transition from Stage 3 → Stage 4
With PMN defect → Stages 1-2 are impaired → bacteria persist → accelerate to Stage 4
Exam flag: Frequently asked as "describe the stages of inflammatory periodontal lesion" with an extension question: "How does aggressive periodontitis alter the normal progression?"
Modification between editions: Later editions (e.g., Lindhe 6th ed.) add cytokine profiles (IL-1β, TNF-α, PGE₂, RANKL/OPG ratio) to each stage - this expanded version is what examiners now expect.
NORMAL: OPG (Decoy receptor) >> RANKL → Bone preserved
IN AgP:
Bacterial LPS / IL-1β / TNF-α / PGE₂
↓
Fibroblasts, T-cells, PMNs upregulate RANKL expression
↓
RANKL binds RANK on osteoclast precursors
↓
Osteoclast differentiation and activation
↓
BONE RESORPTION (RAPID)
↓
OPG is INSUFFICIENT to counteract RANKL
↓
Net result: RANKL >> OPG → Aggressive bone loss
Key cells producing RANKL in AgP:
T-helper cells (Th17), activated fibroblasts, osteoblasts
Exam flag: RANKL/OPG axis questions appear frequently in MDS theory as "mechanism of bone loss in aggressive periodontitis." This is one diagram where textbook versions differ - older Carranza editions omit RANKL; newer editions (11th+) include it.
Y-axis: Cytokine level (PGE₂ ng/mL or IL-1β pg/mL)
X-axis: Groups
Bar 1: Normal controls → baseline levels
Bar 2: Chronic periodontitis → moderately elevated
Bar 3: LAP patients → MARKEDLY elevated (2-3x controls)
Bar 4: GAP patients → elevated (similar or higher to LAP)
Key finding: Same LPS stimulus → MORE cytokine output in AgP patients
This is an INTRINSIC monocyte trait (not environmentally induced)
Exam flag: Often paired with the PMN chemotaxis defect question. Mechanism: overproduction of PGE₂ and IL-1β → enhanced osteoclast activity → rapid bone destruction. This explains why AgP patients have disproportionate destruction relative to plaque levels.
DIAGNOSIS: Aggressive Periodontitis (1999) / Grade C, Stage III/IV (2018)
↓
PHASE 1 (Non-surgical / Etiotropic):
├── Thorough supra/subgingival debridement (SRP)
├── Oral hygiene instructions
├── SYSTEMIC ANTIBIOTICS (ADJUNCT - MANDATORY in AgP)
│ ├── Drug of choice: Amoxicillin 500mg + Metronidazole 400-500mg × 3/day × 7 days
│ ├── Alternative (Aa-resistant): Ciprofloxacin + Metronidazole
│ └── Timing: START WITH OR IMMEDIATELY AFTER SRP (not before)
└── Evaluate response at 6-8 weeks
↓
REASSESSMENT:
├── Resolved → Maintenance (3-monthly initially)
└── Residual pockets (>5 mm) or bone defects → PHASE 2
↓
PHASE 2 (Surgical):
├── Resective surgery (if pockets persist, no regeneration potential)
├── Regenerative surgery (GTR/bone grafts for angular/vertical defects)
│ └── Particularly indicated in first molar vertical defects of LAP
└── Consider: Family screening + prophylactic treatment of siblings
↓
MAINTENANCE:
├── 3-monthly for 1st year, then 4-6 monthly
├── Monitor for recurrence (AgP can recur even after treatment)
└── Re-culture for Aa if required
Exam flag: The antibiotic regimen (Amoxicillin + Metronidazole combination) for AgP is one of the most tested prescriptions in MDS periodontology. Also tested: "Why systemic antibiotics and not local delivery?" Answer: Aa invades tissue - local delivery cannot reach it; systemic therapy is required.
Modification warning: This table exists in older Carranza (10th/11th ed.) but is absent or greatly de-emphasized in the 13th ed. and the 2022 Essentials. If an examiner asks about RPP, it is now classified as Grade C periodontitis in a patient >35 years old.
| Priority | Diagram | Most Frequently Asked In |
|---|---|---|
| ⭐⭐⭐⭐⭐ | 1. 1999 vs 2018 Classification Comparison Table | Long answer / short answer |
| ⭐⭐⭐⭐⭐ | 2. Staging & Grading Matrix (with all values) | Long answer / table completion |
| ⭐⭐⭐⭐⭐ | 3. Primary & Secondary Features of AgP | Short answer / viva |
| ⭐⭐⭐⭐⭐ | 4. PMN/Neutrophil Chemotaxis Defect (Van Dyke) | Short answer / mechanism question |
| ⭐⭐⭐⭐⭐ | 5. Treatment Flowchart (with antibiotic regimen) | Long answer / applied question |
| ⭐⭐⭐⭐ | 6. LAP vs GAP Comparison Table | Short answer |
| ⭐⭐⭐⭐ | 7. Arc-shaped bone loss diagram (radiograph) | Viva / applied |
| ⭐⭐⭐⭐ | 8. Aa Virulence Factors (JP2 clone especially) | Long answer |
| ⭐⭐⭐ | 9. Page & Schroeder Stages (modified for AgP) | Essay question |
| ⭐⭐⭐ | 10. RANKL/OPG Ratio Diagram | Mechanism question |
| ⭐⭐⭐ | 11. Hyperresponsive Monocyte Phenotype | Short answer |
| ⭐⭐ | 12. Familial Aggregation Pedigree | Viva |
| ⭐⭐ | 13. Epidemiological Prevalence Chart | Data/statistics question |
| Issue | Original Paper | Textbook Version | Exam Impact |
|---|---|---|---|
| JP2 clone leukotoxin deletion size | 530 bp deletion (Brogan et al., 1994) | Some texts say "530 bp," others "large deletion" without specifying | State 530 bp precisely |
| % of LAP patients with PMN defect | 75-90% (Van Dyke 1980; varies by study) | Some texts cite 75%, others 90% | Use "approximately 75-90%" |
| Inheritance pattern | Marazita 1994: Autosomal dominant + race-specific heterogeneity | Some texts also list X-linked dominant as alternative | Mention both; state AD is more widely accepted |
| Antibiotic duration | Guerrero 2005: 7 days | Some older texts: 14 days | Current evidence: 7 days is adequate and minimizes resistance |
| AgP as separate entity | Retained in 1999 classification | Removed in 2018 classification (Caton et al.) | Know BOTH; many Indian MDS exams still use 1999 terminology |
| Grade C % bone loss/age threshold | Tonetti 2018: >1.0 | Reproduced correctly in most texts | >1.0 is the specific value |
| LAP serum antibody | Elevated IgG to Aa in LAP (Sjödin et al.) | Some texts say "elevated," others quantify titers | Describe it as "markedly elevated" (protective role, contributes to self-arrest) |
| Hyperresponsive macrophage | Garrison 1989, Shapira 1994: PGE₂ is the key mediator | Newer texts add IL-1β and TNF-α | Mention ALL three: PGE₂, IL-1β, TNF-α |
| Reference | PMID | DOI | Significance |
|---|---|---|---|
| Armitage GC. Ann Periodontol 1999 | 10863370 | 10.1902/annals.1999.4.1.1 | 1999 classification - defines AgP |
| Caton JG et al. J Periodontol 2018 | 29926946 | 10.1002/JPER.18-0157 | 2018 classification - abolishes AgP term |
| Tonetti MS et al. J Clin Periodontol 2018 | 29926495 | 10.1111/jcpe.12945 | Staging & Grading framework |
| Fine DH et al. J Periodontol 2018 | 29926947 | 10.1002/JPER.16-0712 | Classification & diagnosis of AgP (2018) |
| Albandar JM. Periodontol 2000 2014 | 24738584 | 10.1111/prd.12014 | Case definition & diagnostic criteria |
| Kononen E, Muller HP. Periodontol 2000 2014 | 24738586 | - | Microbiology review |
| Van Dyke TE et al. Infect Immun 1980 | 7358424 | - | PMN chemotaxis dysfunction - landmark |
| Van Dyke TE et al. J Dent Res 1983 | 6575033 | - | C5a receptor defect in LJP/LAP |
| Haubek D, Johansson A. J Oral Microbiol 2014 | 25206940 | - | JP2 clone pathogenicity review |
| Gholizadeh P et al. Microb Pathog 2017 | 29117508 | - | Aa virulence factors |
| Page RC, Schroeder HE. Lab Invest 1976 | 765622 | - | Stages of inflammatory periodontal lesion |
| Baer PN. J Periodontol 1971 | Not indexed | - | First description of arc-shaped bone loss in juvenile periodontitis |
Final exam tip: Indian MDS periodontology theory papers (RGUHS, MUHS, RAJIV GANDHI, etc.) frequently still phrase questions using the old terminology ("aggressive periodontitis," "LAP," "GAP") even after 2018. Know BOTH classification systems fluently and state at the start of your answer: "Under the 1999 Armitage classification, this entity was called Aggressive Periodontitis; under the 2018 World Workshop classification, it is now classified as Periodontitis Grade C with molar-incisor pattern (for localized form) or generalized Grade C periodontitis."